November 22nd 2024
The producer of botanical ingredients and organic berries is expanding to reach customers in the U.S. and Canada.
Hemp CBD extract supports sleep, reduces appetite, and improves quality of life in study
July 1st 2019A recent randomized, double-blind, placebo-controlled clinical study conducted by the Center for Applied Health Sciences found that a hemp oil extract manufactured by CV Sciences supported sleep, reduced appetite, and improved the overall quality of life.
Amla supports endothelial function, oxidative stress, and immune health, says recent study
June 25th 2019A study recently published in BCM Complementary and Alternative Medicine shows that a standardized extract of Phyllanthus emblica fruit, otherwise known as amla, supports endothelial function, oxidative stress, immune response, and lipid profile.
More urologists are recommending cranberry PACs for reducing UTIs. Here’s why.
June 19th 2019The American Urological Association’s new guidelines emphasize the need for non-antibiotic alternatives for reducing recurrent urinary tract infections-and highlight cranberry as an effective means of prevention.
Atrium Innovations uses Geocann’s VESIsorb for CBD delivery
June 5th 2019Atrium Innovations is now using VESIsorb, a patented delivery system for improving ingredient absorption, for hemp cannabidiol (CBD) products in its healthcare-professional brands Pure Encapsulations, Douglas Laboratories, and Genestra Brands.
Supplement industry to FDA on CBD regulations: “We can’t wait years”
May 31st 2019At FDA’s highly anticipated public hearing on hemp cannabidiol (CBD) today, May 31, the message from dietary supplement industry representatives was clear: The supplement industry needs a regulatory pathway for CBD-and needs it now.
Beyond CBD: Other cannabinoids in hemp and their exciting potential as ingredients
May 30th 2019CBD may be the hottest ingredient on the block, but don’t overlook hemp’s other promising cannabinoids, including cannabigerol (CBG), cannabichromene (CBC), and cannabinol (CBN). This article discusses exciting avenues of product development for manufacturers looking to work with a wider range of cannabinoids, as well as the challenges that remain.
A major double-blind, placebo-controlled trial will study CBD on joint mobility in dogs
May 29th 2019The largest scale trial conducted on pets to have commenced to date, the trial will evaluate the effectiveness of hemp-based natural supplements on joint mobility in dogs suffering from inflammation secondary to osteoarthritis.
CBD may reduce symptoms of PTSD, says a recently published study
May 21st 2019A retrospective case series published in The Journal of Alternative and Complementary Medicine found that administration of oral CBD in addition to routine psychiatric case was associated with post traumatic stress disorder (PTSD) reduction.